Insider filing
Traded Sep 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Planned for Sep 4, 2026 · Notice filed Sep 4, 2026
An Illumina director told the SEC about a plan to sell $32M of Illumina shares around Sep 4, 2026. The shares were not acquired as compensation. That is a tiny part of all Illumina shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider filing
Traded Sep 30 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Sep 30 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Federal contracts
"eo 14398" five (5) genomic sequencing systems miseq I100 plus systems
The Department of Health and Human Services has committed $575K to Illumina so far. The contract could grow to $871K. It runs until Nov 16, 2027.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.